A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal approval and patient uptake could be a challenge ... mlive: Vaccine for Lyme disease shows promise in clinical trial amid rise in tick bites Vaccine for Lyme disease shows promise in clinical trial amid rise in tick bites CBS News: Pfizer working for approval on new Lyme disease vaccine as expert says tick activity rising in New England. Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see pushback from the government following studies done on the vaccine.

Context Explanation

"What ... Pfizer working for approval on new Lyme disease vaccine as expert says tick activity rising in New England. Fierce Biotech: Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story